Floatz logo

amr101

Colorectal Adenoma

Massachusetts General HospitalSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Colorectal Adenoma cohort.

Asset / SponsorPhaseRating
UMBELLATINE
Jing-yuan Fang, MD, Ph. D
Phase 2/3B
Mesalamine
UMC Utrecht
Phase 2B
Dfn-15
University of Alabama at Birmingham
Phase 2B
Linaclotide
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2CCC
Acetylsalicylic Acid
University of Edinburgh
Phase 2CCC

View all 11 →

Same molecule, other indications

amr101 is also rated in:

cardiovascular disorderDormant
B
Indicative ·
60 / 100
View asset →
colon carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
colorectal cancerDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →